Clari Vest Asset Management LLC Acadia Pharmaceuticals Inc Transaction History

Clari Vest Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$17.79 - $30.86 $551 - $956	31 Added 0.11%	28,335 $523,000
Q4 2023 Feb 13, 2024	SELL	$20.78 - $31.77 $103,900 - $158,850	-5,000 Reduced 15.01%	28,304 $886,000
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $694,055 - $1.11 Million	33,304 New	33,304 $694,000
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $1.37 Million - $3.02 Million	-54,880 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$41.04 - $56.79 $16,416 - $22,716	-400 Reduced 0.72%	54,880 $2.93 Million
Q3 2020 Nov 09, 2020	SELL	$36.42 - $57.0 $43,339 - $67,830	-1,190 Reduced 2.11%	55,280 $2.28 Million
Q2 2020 Aug 12, 2020	SELL	$39.26 - $52.73 $2.54 Million - $3.41 Million	-64,581 Reduced 53.35%	56,470 $2.74 Million
Q1 2020 May 04, 2020	SELL	$31.65 - $46.87 $105,046 - $155,561	-3,319 Reduced 2.67%	121,051 $5.11 Million
Q4 2019 Feb 12, 2020	SELL	$36.21 - $51.4 $1.38 Million - $1.96 Million	-38,196 Reduced 23.5%	124,370 $5.32 Million
Q3 2019 Nov 12, 2019	BUY	$22.22 - $44.01 $3.61 Million - $7.15 Million	162,566 New	162,566 $5.85 Million

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.